ARCHIVES

FDA Faces Severe Regulatory, Scientific Needs, Report Finds.

This article is from The Cancer Letter archive.

Vol. 34 No. 04 | February 1, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Move From Westwood, Landow, Blair Bldgs; Kinsella Names UW Oncology Chairman

October 9, 1987

NCAB Member Becker Says AACR ‘Feels Disenfranchised’

December 6, 1991

In Brief: House Passes Bill Extending Saccharin Status To 1981; Execs No Enthusiastic Over New SES

August 3, 1979

Five Year Plan for Cancer centers Called ‘East Bloc ’ Directive

February 2, 1990

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002